Inactive Endometrium: Understanding Your Pathology Report

Section Editor: Kianoosh Keyhanian MD FRCPC
September 1, 2026

Inactive endometrium describes a lining of the uterus that is not responding to hormones. The lining is called the endometrium, and it normally thickens and sheds each month under the influence of estrogen and progesterone. When those hormones are absent, low, or blocked, the lining stops cycling. It becomes thin and quiet, and that is what pathologists mean by inactive.

This is a benign finding. It is not cancer, and it is not precancerous. It is a description of a state rather than a disease, and in many situations it is exactly what should be there.

Your report may instead say atrophic endometrium. The two terms describe the same finding, and pathologists use them interchangeably. This article will help you understand what the term means on your report and how to read it in your own situation.

What causes an inactive endometrium?

The lining of the uterus is built and maintained by two hormones from the ovary. Anything that removes those hormones, lowers them, or blocks their effect will produce an inactive lining.

Menopause — The most common reason. Once the ovaries stop producing estrogen, the lining becomes thin and stays that way. This is the expected finding after menopause.
Before puberty — The lining is inactive until the hormonal cycle begins.
Hormonal medications — Combined pills, progestin-only pills, the contraceptive injection, the implant, and hormonal IUDs all thin the lining. This is an intended effect, and it is why several of them reduce or stop bleeding.
Medications that suppress the ovaries — Treatments given for endometriosis, fibroids, or breast cancer switch off ovarian hormone production. The effect is usually reversible when the medication stops.
Loss of ovarian function — Surgery to remove both ovaries, chemotherapy, radiation, or premature ovarian insufficiency, which is loss of ovarian function before the age of 40.
Signals from the brain being interrupted — The ovaries are directed by the brain. Very low body weight, intense exercise, prolonged stress, or certain pituitary conditions can interrupt those signals, so the ovaries stop producing hormones even though they are healthy.

Because the appearance depends so much on medication, that information genuinely helps the pathologist interpret the sample. If you use a hormonal IUD or take any hormone medication, it should be written on the requisition form that goes to the laboratory with your tissue.

What are the symptoms?

An inactive endometrium usually causes no symptoms. In many people,e it is the reason periods have become light or stopped altogether, which is an expected effect of the medication or the life stage rather than a problem.

When it does cause a symptom, that symptom is bleeding. A very thin lining is fragile, and its surface can break down and bleed. This is the most common explanation for bleeding after menopause. It is also a common cause of the irregular spotting many people notice in the first months after starting a hormonal IUD or implant.

How is the diagnosis made?

Inactive endometrium is identified by a pathologist examining a sample of the lining under the microscope. The sample usually comes from an endometrial biopsy, a brief clinic procedure using a thin flexible tube, or from a dilation and curettage. It may also be found in a uterus removed at surgery.

Bleeding after menopause is always investigated, because roughly 1 in 10 people who have it turn out to have endometrial cancer. Evaluation usually involves both an ultrasound to measure the lining thickness and a tissue sample. Guidance changed in 2026. A thin ultrasound measurement is no longer considered sufficient on its own, and tissue sampling is now recommended as part of the initial evaluation.

One practical point comes up often. An inactive lining is very thin, so there is little tissue to collect. Reports frequently describe the sample as scant, fragmented, or insufficient for evaluation. This is common and does not mean anything went wrong, but it does mean a small abnormality may not have been sampled.

What does inactive endometrium look like under the microscope?

Inactive endometrium is a thin lining of the uterus in which the glands are small, and the tissue shows no sign of hormonal stimulation. Under the microscope, the pathologist looks for the following features.

A thin strip of tissue — Samples often consist of small strips of surface lining rather than full-thickness tissue, simply because there is so little of it.
Small, widely spaced glands — The glands are few, small, and set far apart. Some are rounded and filled with fluid, which the report may call cystic change.
Flat lining cells — The cells forming the glands are low and flat rather than the tall column shape seen when the lining is growing.
Very few dividing cells — Cells caught in the act of dividing are rare or absent, reflecting a lining that is not rebuilding.
Quiet supporting tissue — The stroma between the glands looks dense and inactive rather than cellular. Under some hormonal medications,s it takes on a distinctive appearance instead, described below.

What does this finding mean in my situation?

Inactive endometrium is always a benign appearance, but whether it is the expected appearance depends on your circumstances.

After menopause — Exactly what should be found. If you had bleeding, this is usually the explanation.
While using a hormonal IUD or contraceptive — The intended effect. The report may describe a thin lining with inactive glands and altered supporting tissue, sometimes called a progestin effect. It confirms the medication is doing what it is meant to do.
While taking a medication that suppresses the ovaries — Also expected, and usually reversible once the medication is stopped.
Before menopause, taking no hormones — This is the situation worth asking about. An inactive lining here means the ovaries are not producing their usual hormones, and the reason is worth identifying.

In that last situation, several explanations are possible. Premature ovarian insufficiency, meaning loss of ovarian function before 40, is one. Interrupted signaling from the brain, from very low body weight, intense exercise, prolonged stress, or a pituitary problem, is another. Previous chemotherapy or radiation can also be responsible. Each can affect bone health and fertility. In a younger person, this finding is a reason to ask what lies behind it rather than something to leave in the report.

How is this different from other descriptions of the endometrium?

Pathologists use several terms to describe the lining, and most describe normal states rather than diseases. Your report may use any of the following.

Inactive or atrophic endometrium — Thin and not responding to hormones. Two names for the same finding.
Proliferative endometrium — Actively growing under estrogen. Proliferative endometrium is normal before menopause, and after menopause it means estrogen is reaching the lining from somewhere.
Secretory endometrium — Changed by progesterone after ovulation. Secretory endometrium confirms that ovulation occurred.
Disordered proliferative endometrium — Irregular, unevenly spaced glands from estrogen without progesterone. Disordered proliferative endometrium is not precancerous.
Endometrial hyperplasia — Crowded glands from prolonged estrogen stimulation. Endometrial hyperplasia is treated and followed.

What other findings may be described in the report?

Inactive endometrium is often reported alongside other findings from the same sample.

Endometrial polyp — An endometrial polyp is a benign overgrowth of the lining and a common cause of bleeding. Polyps can sit within an otherwise inactive lining.
Surface breakdown — Areas where the fragile surface has broken down, often the direct explanation for bleeding.
Chronic endometritis — If plasma cells are present in the supporting tissue, the report may add a diagnosis of chronic endometritis. This is a separate finding reported alongside an inactive lining, not a cause of it.
Negative for hyperplasia and malignancy — A standard phrase meaning the pathologist looked for crowded glands and for cancer and found neither.
Sample adequacy — A comment that the sample was scant or insufficient. Very common with a thin lining, and worth asking about if you are still bleeding.

What happens next?

An inactive endometrium needs no treatment in its own right. It is a state, not a condition to be corrected. What happens next depends on your age, symptoms, and medications. Points your doctor may raise include:

If the bleeding has stopped — No further testing is usually needed for this finding.
If the bleeding continues — Further evaluation is recommended, usually a hysteroscopy, since a small abnormality may not have been captured in a scant sample.
If a medication explains it — Nothing needs to change. Confirming this rather than assuming it is worthwhile.
If you are under 40 and take no hormones — Investigation of why the ovaries have stopped working, including hormone tests and, where appropriate, assessment of bone health and fertility.
Vaginal symptoms — Dryness and discomfort share the same low-estrogen cause and are treated separately, usually with vaginal estrogen.

Questions to ask your doctor

Is this finding expected for my age?
Could my medication or IUD explain this result?
Does this result explain the bleeding I had?
Was the sample adequate, or was it too small to be fully reassuring?
Does my report say negative for hyperplasia and malignancy?
Was a polyp or any other finding reported?
I have not gone through menopause. Why is my lining inactive?
Should I have hormone tests to look for a cause?
What does this mean for my fertility?
Should I have my bone density checked?
What should I do if the bleeding comes back?
Do I need any follow-up or repeat testing?